The Innovation Imperative: Tackling Antimicrobial Resistance
The modern antibiotic industry is at a critical crossroads. For decades, the continuous introduction of new antibacterial agents kept healthcare systems one step ahead of evolving pathogens. However, the discovery pipeline has slowed to a trickle, leading to a dangerous rise in multidrug-resistant organisms. This escalating crisis is fundamentally reshaping the financial priorities and clinical...
0 Kommentare 0 Geteilt 14 Ansichten 0 Bewertungen
SocioMint https://sociomint.com